Opinion: Broadcom Is the Canary in the AI Coal Mine -- Just Not in the Way You Think

Broadcom reported Q2 revenue of $22.2 billion, up 48% year over year and above estimates, but investors sold the stock after full-year AI chip revenue guidance remained vague at "in excess of $100 billion" instead of being raised. The article argues the 14% intraday drop is more a valuation reset than a fundamental break, with shares still near 20x next year's expected earnings versus an analyst consensus target of $505.75. The move also pressured other AI-related tech stocks as investors reassessed elevated multiples.

Analysis

This looks less like a fundamental air-pocket in AVGO and more like a positioning unwind in the highest-multiple corner of AI. When a stock is priced for persistent estimate raises, merely meeting a vague long-range target is functionally a miss; the first-order reaction is mechanical multiple compression, not a thesis break. That matters because the weakest link is sentiment elasticity: names that have benefited most from “AI capital spending forever” are the most vulnerable when guidance fails to force upward revisions.

Second-order, the read-through is broader than semis. If investors are using AVGO as a proxy for AI infrastructure monetization, the selloff can pressure adjacent “AI beta” even when their own fundamentals are unchanged. NVDA is the cleaner relative winner on the other side because its earnings cadence and demand visibility are still better understood, so any rotation out of ambiguous AI monetization into clearer near-term execution should favor it versus supply-chain-adjacent beneficiaries with less transparency.

The key risk to the bearish crowd is that this may be a valuation reset, not an earnings reset, and those tend to mean-revert quickly once analysts re-anchor price targets. If AI capex revisions remain positive into the next 1-2 quarters, the stock can recover most of the drawdown without requiring a new narrative. The real downside tail is if this becomes the first evidence that hyperscaler budgets are being questioned, but that would need follow-through in peers and capex commentary, not one guide.

Contrarian takeaway: the move is likely overdone for investors with a 6-12 month horizon, but not necessarily for traders. The cleaner opportunity is to buy dislocation after the forced de-risking passes, rather than assuming the trough is immediate. The market is likely pricing in a worst-case demand elasticity story when what it has actually seen is a communication/expectations gap.

Key Decisions for Investors

• Avoid chasing AVGO on the first bounce; wait for 1-2 sessions of stabilization or analyst target resets before re-entering, since near-term upside is likely dominated by multiple repair rather than fundamentals.
• Pair trade: long NVDA / short AVGO for 2-6 weeks if the market keeps rewarding clearer AI monetization and punishing vague forward guidance; thesis breaks if AVGO gets a fresh estimate hike or NVDA guidance softens.
• For longer-term accounts, sell cash-secured puts on AVGO 8-12% below spot with 30-60 DTE to get paid for volatility while positioning for a valuation mean reversion.
• If you already own AI-beta baskets, reduce low-visibility names and rotate toward higher-quality execution/visibility leaders over the next 1-3 weeks; use AVGO’s drawdown as the signal that the market is tightening selectivity.
• Set a tactical alert on AVGO for a further 5-8% drawdown below current levels; that zone is where the risk/reward improves materially for a 6-12 month long, assuming no deterioration in hyperscaler capex commentary.